BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Terzi C, Arslan NC, Canda AE. Peritoneal carcinomatosis of gastrointestinal tumors: Where are we now? World J Gastroenterol 2014; 20(39): 14371-14380 [PMID: 25339824 DOI: 10.3748/wjg.v20.i39.14371] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Pletcher E, Gleeson E, Labow D. Peritoneal Cancers and Hyperthermic Intraperitoneal Chemotherapy. Surg Clin North Am 2020;100:589-613. [PMID: 32402303 DOI: 10.1016/j.suc.2020.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Rana SS, Bhasin DK. EUS: a panacea for detection of peritoneal carcinomatosis! Gastrointest Endosc 2015;81:1225-7. [PMID: 25864895 DOI: 10.1016/j.gie.2014.12.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Yong ZZ, Tan GHC, Wong JFS, Lim C, Soo KC, Teo MCC. Unresectability during open surgical exploration in planned cytoreductive surgery and hyperthermic intraperitoneal chemotherapy*. International Journal of Hyperthermia 2016;32:889-94. [DOI: 10.1080/02656736.2016.1221146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
4 Morano WF, Aggarwal A, Love P, Richard SD, Esquivel J, Bowne WB. Intraperitoneal immunotherapy: historical perspectives and modern therapy. Cancer Gene Ther. 2016;23:373-381. [PMID: 27834358 DOI: 10.1038/cgt.2016.49] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
5 Schindler P, Kupcinskas J, Juzenas S, Skieceviciene J, Salteniene V, Schulz C, Weigt J, Malfertheiner P, Link A. Expression of microRNAs in the ascites of patients with peritoneal carcinomatosis and peritonitis. Cancer Cytopathol. 2018;126:353-363. [PMID: 29360196 DOI: 10.1002/cncy.21966] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
6 Shao S, Yang X, Zhang Y, Wang X, Li K, Zhao Y, Mou X, Hu P. Oncolytic Virotherapy in Peritoneal Metastasis Gastric Cancer: The Challenges and Achievements. Front Mol Biosci 2022;9:835300. [DOI: 10.3389/fmolb.2022.835300] [Reference Citation Analysis]
7 Minnaert AK, Dakwar GR, Benito JM, García Fernández JM, Ceelen W, De Smedt SC, Remaut K. High-Pressure Nebulization as Application Route for the Peritoneal Administration of siRNA Complexes. Macromol Biosci 2017;17. [PMID: 28614632 DOI: 10.1002/mabi.201700024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
8 Breuer E, Hebeisen M, Schneider MA, Roth L, Pauli C, Frischer-Ordu K, Eden J, Pache B, Steffen T, Hübner M, Villeneuve L, Kepenekian V, Passot G, Gertsch P, Gupta A, Glehen O, Lehmann K. Site of Recurrence and Survival After Surgery for Colorectal Peritoneal Metastasis. J Natl Cancer Inst 2021;113:1027-35. [PMID: 33484560 DOI: 10.1093/jnci/djab001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Castro-mesta J, González-guerrero J, Barrios-sánchez P, Villarreal-cavazos G. Bases and foundations of the treatment of peritoneal carcinomatosis: Review article. Medicina Universitaria 2016;18:98-104. [DOI: 10.1016/j.rmu.2016.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Zhang C, Plambeck BD, Craig ME, Tu A, Mikus RJ, Shostrom V, McDermott SP, Igbinigie I, Brown K, Cushman-Vokoun A, Foster JM. Exploring the prognostic and therapeutic utility of expanded mutation profiling in appendix peritoneal metastasis managed with CRS/HIPEC. J Surg Oncol 2021;123:1599-609. [PMID: 33667317 DOI: 10.1002/jso.26439] [Reference Citation Analysis]
11 Nowacki M, Zegarski W. The scientific report from the first pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures performed in the eastern part of Central Europe. J Int Med Res 2018;46:3748-58. [PMID: 29916281 DOI: 10.1177/0300060518778637] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Binda C, Dabizzi E, Sinagra E, Fornelli A, Saragoni L, Cennamo V, Anderloni A, Fabbri C. Micro-Biopsy Forceps in the Assessment of Peritoneal Carcinomatosis: A Possible New Indication? Clin Endosc 2021;54:613-7. [PMID: 33765374 DOI: 10.5946/ce.2020.241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Zaidi MY, Lee RM, Gamboa AC, Speegle S, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Dessureault S, Kelly KJ, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Hendrix RJ, Lambert L, Ronnekleiv-Kelly S, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Fackche N, Russell MC, Maithel SK, Staley CA 3rd. Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative. Ann Surg Oncol 2020;27:156-64. [PMID: 31602579 DOI: 10.1245/s10434-019-07626-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
14 Allen CJ, Blumenthaler AN, Das P, Minsky BD, Blum M, Roy-Chowdhuri S, Ajani JA, Ikoma N, Mansfield PF, Badgwell BD. Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma. World J Surg Oncol 2020;18:39. [PMID: 32066454 DOI: 10.1186/s12957-020-01813-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Zhang C, Patel A, Hegeholz D, Brown K, Shostrom V, Pottebaum M, Foster JM. Cytoreductive Surgery with HIPEC is a Safe and Effective Palliative Option in Chemorefractory Symptomatic Peritoneal Metastasis. Ann Surg Oncol 2022. [PMID: 35211861 DOI: 10.1245/s10434-022-11323-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]